Previous close | 114.53 |
Open | 112.28 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 110.92 - 112.28 |
52-week range | 97.31 - 122.66 |
Volume | |
Avg. volume | 5,137 |
Market cap | 59.409B |
Beta (5Y monthly) | 0.33 |
PE ratio (TTM) | 64.49 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.44 (1.26%) |
Ex-dividend date | 18 Apr 2024 |
1y target est | N/A |
While it's true that diversification is key when it comes to safe and reliable investing, these two passive income stocks tickle my fancy. The post 2 spectacular passive income stocks I’d feel confident going all in on appeared first on The Motley Fool UK.
AstraZeneca has suffered an investor backlash over a £19m pay award for its chief executive, in a vote that will deepen concerns of an exodus of UK companies to the US.
Shell's CEO has expressed dissatisfaction with the London Stock Exchange's valuation, indicating the possibility of exploring other options, including the abandonment of its London listing.